首页> 美国卫生研究院文献>Cell Death Disease >Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinsons disease
【2h】

Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinsons disease

机译:microRNA的失调对伴侣介导的自噬和帕金森病中α-突触核蛋白病理学的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The presence of α-synuclein aggregates in the characteristic Lewy body pathology seen in idiopathic Parkinson's disease (PD), together with α-synuclein gene mutations in familial PD, places α-synuclein at the center of PD pathogenesis. Decreased levels of the chaperone-mediated autophagy (CMA) proteins LAMP-2A and hsc70 in PD brain samples suggests compromised α-synuclein degradation by CMA may underpin the Lewy body pathology. Decreased CMA protein levels were not secondary to the various pathological changes associated with PD, including mitochondrial respiratory chain dysfunction, increased oxidative stress and proteasomal inhibition. However, decreased hsc70 and LAMP-2A protein levels in PD brains were associated with decreases in their respective mRNA levels. MicroRNA (miRNA) deregulation has been reported in PD brains and we have identified eight miRNAs predicted to regulate LAMP-2A or hsc70 expression that were reported to be increased in PD. Using a luciferase reporter assay in SH-SY5Y cells, four and three of these miRNAs significantly decreased luciferase activity expressed upstream of the lamp-2a and hsc70 3′UTR sequences respectively. We confirmed that transfection of these miRNAs also decreased endogenous LAMP-2A and hsc70 protein levels respectively and resulted in significant α-synuclein accumulation. The analysis of PD brains confirmed that six and two of these miRNAs were significantly increased in substantia nigra compacta and amygdala respectively. These data support the hypothesis that decreased CMA caused by miRNA-induced downregulation of CMA proteins plays an important role in the α-synuclein pathology associated with PD, and opens up a new avenue to investigate PD pathogenesis.
机译:在特发性帕金森病(PD)中所见的特征性路易体病理中存在α-突触核蛋白,以及家族性PD中的α-突触核蛋白基因突变,将α-突触核蛋白置于PD发病机理的中心。 PD脑样本中伴侣介导的自噬(CMA)蛋白LAMP-2A和hsc70水平降低,表明CMA破坏的α-突触核蛋白降解可能是路易体病的基础。降低的CMA蛋白水平不是与PD相关的各种病理变化的继发因素,包括线粒体呼吸链功能障碍,氧化应激增加和蛋白酶体抑制。但是,PD脑中hsc70和LAMP-2A蛋白水平的降低与其各自mRNA水平的降低有关。在PD大脑中已经报道了MicroRNA(miRNA)的失调,并且我们已经确定了八种预测可调节LAMP-2A或hsc70表达的miRNA,这些miRNA据报道在PD中会增加。使用SH-SY5Y细胞中的荧光素酶报告基因检测,这些miRNA中的四个和三个显着降低了分别在lamp-2a和hsc70 3'UTR序列上游表达的荧光素酶活性。我们证实这些miRNA的转染也分别降低了内源性LAMP-2A和hsc70蛋白水平,并导致显着的α-突触核蛋白积聚。对PD脑的分析证实,黑质致密部和杏仁核中的这些miRNA分别有6个和2​​个显着增加。这些数据支持以下假设:由miRNA诱导的CMA蛋白下调引起的CMA降低在与PD相关的α-突触核蛋白病理中起重要作用,并开辟了研究PD发病机理的新途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号